Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
about
Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxisHaemophilia A: pharmacoeconomic review of prophylaxis treatment versus on-demandProfile of efraloctocog alfa and its potential in the treatment of hemophilia A.Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatmentHealth technology assessment and haemophilia.Economic evaluations of prophylaxis with clotting factor for people with severe haemophilia: why do the results vary so much?Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.Making economic evaluations more helpful for treatment choices in haemophilia.Health economic models in hemophilia A and utility assumptions from a clinician's perspective.Treatment adherence in hemophilia.Modelling lifelong effects of different prophylactic treatment strategies for severe haemophilia A.Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy.Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia.
P2860
Q26865814-0E3A668B-B3C7-4ED8-BEF1-80AA0F294175Q28082558-634DDBA6-B706-49AE-87F6-2D4150BD917EQ35565320-B45F1B95-B315-4104-BAF0-5E898186A46AQ35613053-662F7376-D22B-439E-B183-7056C2B061BDQ37984093-4836A7A0-E67D-4EAC-8F69-49FC6DDC221FQ38044472-31AB1A43-935C-4A13-8137-EE42E03EA1E7Q38227605-095393BD-EEDF-4D1A-9FA9-1EDB496A2ECFQ38767186-221A0E5D-8E46-406A-9B1D-275B9C8E9910Q40938357-5F02A9E4-2EF6-4208-A631-992B7FE3D158Q42371331-C4265BD5-C6BF-4E66-9521-4DABA6262B71Q45855703-33DA0445-A82E-47D2-8044-1F083234FF47Q45864589-4AEB501E-B94E-4CCB-B209-E5E7F0E2F214Q45874959-C3E1CFD6-8482-4356-A05B-D2BBD8BB5C38Q45886531-1385EE89-8CA7-4CD8-96C8-DE8529956D3D
P2860
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@ast
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@en
type
label
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@ast
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@en
prefLabel
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@ast
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@en
P2093
P2860
P356
P1476
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
@en
P2093
Elena Santagostino
Giorgio L Colombo
Maria Elisa Mancuso
Sergio Di Matteo
P2860
P356
10.2147/CEOR.S16670
P407
P577
2011-03-14T00:00:00Z